Primary immunodeficiency diseases (PIDs) are characterized by an increased risk of infections, autoimmunity, autoinflammation, malignancy, and allergic disorders. Skin disorders are also common clinical features in PIDs and may be among the presenting manifestations. Recognition of specific PID-associated skin conditions in combination with other clinical features as described in the currently used warning signs could raise suspicion of an underlying PID. We aimed to provide a systematically obtained overview of skin disorders and their prevalence in PIDs. Secondary, the prevalence of Staphylococcus (S.) aureus-associated skin disorders and atopy was reviewed, as these are the most prominent skin features in PIDs. A systematic search was performed in EMBASE, MEDLINE, Web of Science, Cochrane, and Google Scholar (up to May 9, 2018). All original observational and experimental human studies that address the presence of skin disorders in PIDs were selected. We rated study quality using the Institute of Health Economics Quality Appraisal Checklist for Case Series Studies. Sixty-seven articles (5030 patients) were included. Study quality ranged from 18.2% to 88.5%. A broad spectrum of skin disorders was reported in 30 PIDs, mostly in single studies with a low number of included patients. An overview of associated PIDs per skin disorder was generated. Data on S. aureus-associated skin disorders and atopy in PIDs were limited. In conclusion, skin disorders are prominent features in PIDs. Through clustering of PIDs per skin disorder, we provide a support tool to use in clinical practice that should raise awareness of PIDs based on presenting skin manifestations.
skin disorders reported in PIDs, including leukocyte adhesion defects (LAD), chronic granulomatous disease (CGD), severe congenital neutropenia, and hyper-IgE syndrome (HIES). [9] [10] [11] On the other hand, dermatitis is one of the most prominent noninfectious skin manifestations in PIDs and may be part of the atopic syndrome. 12 Patients with an atopic constitution show next to atopic dermatitis (AD) tendency toward development of food allergies, asthma, and rhinoconjunctivitis. 13 Based on previous narrative reviews without a systematic approach, S. aureus skin infections, dermatitis, and other skin disorders as well as atopy seem to be all fairly common in patients with a PID, but are also frequently described in the general population. 12 Therefore, it is of importance to realize that presence of specific skin symptoms alone does not necessarily point toward a PID. However, recognition of specific skin conditions in combination with other clinical features suggestive of an immunodeficiency should raise awareness to an underlying PID and may facilitate earlier diagnosis of PIDs. 14 The aim of this review was to provide a systematically obtained overview of skin disorders and their prevalence in patients with
PIDs. Focusing on two prevalent skin disorders in PIDs, the relation between PIDs and S. aureus-related skin disorders and atopy will be reviewed in more detail.
2 | ME TH ODS
| Studies
This review with a systematic approach was conducted and reported according to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines, where applicable. 15 All original observational and experimental human studies were included. We selected both articles reporting skin disorders in patients with PIDs and articles presenting a differential diagnosis of a specific skin disorder that includes a PID. No restrictions were made with respect to publication date and language. We excluded case reports (<5 patients), conference abstracts, letters, and editorials as the quality of these types of articles can be highly variable. Also articles describing acquired immunodeficiencies, articles reporting skin disorders in PIDs that developed after or during treatment/intervention, and articles in which the description of skin disorders in PIDs was not part of the results section were excluded. Data on skin disorders were only extracted if at least five patients per PID were reported.
| Study participants
Patients of all ages with a PID according to Picard et al 16 from both hospital setting and general population were included.
| Study outcomes
The primary outcome is the presence of skin disorders in PIDs. Secondary outcomes include the prevalence of skin disorders in PIDs, S. aureus-associated skin disorders in PIDs, and PIDs associated with an atopic constitution (ie, atopic dermatitis, food allergy, asthma, rhinoconjunctivitis).
| Search strategy
The electronic search was conducted in EMBASE, MEDLINE, Web of Science, Cochrane, and Google Scholar up to May 9, 2018 ( Table S1 ). The search was composed of terms of the categories primary immunodeficiency, skin disorder, S. aureus, and atopy supplemented by specific PIDs and skin disorders based on recent literature.
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| Study selection and data extraction
All studies identified in the systematic search were screened for relevance by title and abstract. Duplicates and studies that did not meet our inclusion criteria were excluded (Appendix S1).
Remaining articles were assessed for eligibility by full-text review. 
| Analysis of data
The prevalence of skin disorders in PIDs was extracted from the included studies. If required, the prevalence was calculated with the available raw data. Because the reported number of patients with a PID was mainly low, the proportion of patients with a PID and skin disorders was descriptively presented. Proportions of skin disorders in PIDs were compared to the prevalence of skin disorders in the general population. [21] [22] [23] [24] [25] [26] Data from the general population were based on a birth cohort in Finland (n = 1932, age 45-47 years) and a Dermatology outpatient clinic in Turkey (n = 11 040, age 1-99 years). 21, 22 In addition, a nation- 
| Staphylococcus aureus-associated skin disorders in primary immunodeficiency diseases
Skin disorders associated with S. aureus in PIDs were reported in six articles (Table S1 ). In HIES unspecified, 4/7 patients with a papulopustular eruption had a positive S. aureus culture. . 28, 29 Renner et al 30 described that skin abscesses were frequently due to S. aureus infections in AR-HIES. In Comèl-Netherton syndrome, 8/9 described patients showed recurrent or persistent S. aureus skin infections once skin lesions had developed. 31 Lastly, S. aureus was isolated in 1/4 patients with CGD and suppurative dermatitis. 
| Primary immunodeficiency diseases associated with atopy
The prevalence of at least two atopic symptoms (ie, eczema, food allergy, asthma, and/or rhinoconjunctivitis) in PIDs was described in 17 articles (Table S1) The number of patients with eczema, food allergy, asthma, and rhinoconjunctivitis was presented in two studies with hypogammaglobulinemia patients. 38, 39 Eight studies reported the prevalence of atopy in a total of 398 patients with SIgAD, in which 11.6% (46/398) patients had eczema, 3.4% (9/263) had food allergy, 37.1% (43/116) had asthma, and 20.0% (55/275) had rhinoconjunctivitis. 38, [40] [41] [42] [43] In IgM-deficient patients, eczema, asthma, and rhinoconjunctivitis were prevalent symptoms. 38 Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) patients were mainly positive for eczema. 44 Eight of 48 CGD patients had eczema and one out of 18 had rhinoconjunctivitis. 45 Finally, Aderibigbe et al 46 have shown that one to three out of eight patients with phospholipase C gamma 2 (PLCG2) gene associated antibody deficiency and immune dysregulation (PLAID) had eczema, food allergy, asthma, and/or rhinoconjunctivitis. Abbreviation: nm, not mentioned. † Data on the prevalence of skin disorders in the general population were based on a birth cohort in Finland (n = 1932, age 45-47 years) and a Dermatology outpatient clinic in Turkey (n = 11 040, age 1-99 years). 21, 22 In addition, a nationwide study of Furue et al 23 reported the prevalence of cutaneous disorders in 67 448 Japanese patients of all ages. In the study of Verhoeven et al, 24 the skin disease prevalence per 1000 patient-years in family practices in the Netherlands was converted to a point prevalence in the general population (n = 501, age 18-97 years). Last, two studies from the Uni- The exact prevalence of acne-like lesions in chronic granulomatous disease was not reported in the included article. The prevalence of skin disorders per primary immunodeficiency disease was based on the reported proportion of patients with the skin disorders in the total group of patients with the primary immunodeficiency disease. In case of multiple studies reporting a skin disorder in a primary immunodeficiency disease, the general prevalence was calculated by dividing the total number of affected patients (skin disorder) by the total number of patients with the primary immunodeficiency disease. nm, not mentioned.
| DISCUSSION
This review demonstrates that skin disorders are common symptoms in both children and adult patients with PIDs based on data from 67 systematically selected studies. Only a few PIDs related to S. aureus -associated skin disorders or atopy were reported in mainly single studies. This is the first review using a systematic approach without limitations on skin disorders or PIDs. Therefore, we managed to obtain a complete spectrum of skin disorders in PIDs. A recent study of Ettinger et al 47 Our review has some limitations. First of all, exclusion of case reports describing fewer than five cases in our analysis might have resulted in loss of information about skin disorders in rare PIDs.
However, the quality of case reports is highly variable, potential publication bias plays a role, and thus, exclusion of these case reports might have improved the reliability of this review. Furthermore, through the addition of selected PIDs and skin disorders to our electronic search we could have caused a selection bias.
Although we used a cross-reference check, we cannot exclude that we might have missed some articles. Thirdly, demonstrating that specific skin disorders are characteristic for PIDs was not possible.
We could only compare the presence of a number of skin disorders in patients with a PID with the prevalence of skin disorders in the general population based on six studies varying in publication year and age of the studied population. [21] [22] [23] [24] [25] [26] However, most of these skin disorders were more prevalent in patients with a PID compared with the general population. Lastly, the reliability of the description of skin disorders might be questioned since in only 27 of the 67 included articles the Department of Dermatology was involved.
Probably, the described skin disorders were not all diagnosed by a dermatologist, but by an immunologist or pediatrician. Moreover, the majority of studies did not use skin biopsy to confirm the diagnosis of the cutaneous manifestations histopathologically. In severe com- included. Based on data of this review, we suggest to start to collect more detailed data on all skin orders in the ESID registry.
Future research is needed to validate these data and support an association between specific cutaneous symptoms and PIDs.
Given the low number of articles reporting S. aureus-associated skin disorders and atopy in PIDs, more data have to be collected to further improve earlier recognition of PIDs. In addition, data on S. aureus associated skin disorders might provide new treatment options for skin disorders, such as targeted therapy directed against S. aureus.
| CONCLUSION
This review with a systematic approach shows that skin disorders are a prominent feature in PIDs. Earlier diagnosis of PIDs can be facilitated by recognition of specific skin conditions as signal function of PIDs in combination with the current warnings signs for PIDs or by recognizing PID specific clusters of skin conditions. We provide a support tool to use in clinical practice that should raise awareness of PIDs based on the presenting skin manifestations. Limited data are available on S. aureus -associated skin disorders and atopy in PIDs.
